Bionova Scientific

Bionova Scientific Licenses ATUM’s Proprietary Transposon-Based Gene Delivery Technology to Accelerate & De-Risk Cell Line Development

7 May 2025 -- California, US and Düsseldorf, Germany -- Bionova Scientific, an Asahi Kasei boutique commercial-scale biologics contract development and manufacturing organization (CDMO), today announced it has licensed ATUM’s proprietary Leap-In Transposase® transposon-based gene delivery and its miCHO™ cell line development technologies. ATUM’s Leap-In Transposase technology can achieve high levels of gene integration, resulting...

Bionova Scientific announces plans for new Plasmid DNA GMP facility

Facility in The Woodlands, Texas, US, to produce critical starting material for cell and gene therapy, DNA/RNA-based, and recombinant protein therapeutics in Q1/2025 3 June 2024 -- California, US -- Bionova Scientific, an Asahi Kasei Group company and full-service biologics CDMO, announced plans to invest in plasmid DNA (pDNA) production. The centrepiece of the project...
3288 Laurelview Ct. Fremont, CA 94538

+1 510-298-3136